17616664[uid] OR 18555017[uid] OR 20602797[uid] OR 20859956[uid] OR 19403413[uid] OR 21802413[uid] OR 18176954[uid] OR 21814544[uid] OR 22146341[uid] OR 21829663[uid] - Search Results

Year	Number of Results
2007	1
2008	2
2009	1
2010	2
2011	4
2012	1
2021	0

1

Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.

Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF. Diao S, et al. Proteomics. 2010 Oct;10(20):3723-31. doi: 10.1002/pmic.201000050. Proteomics. 2010. PMID: 20859956

2

Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.

Fu X, Rivera A, Tao L, De Geest B, Zhang X. Fu X, et al. Mol Ther. 2012 Feb;20(2):339-46. doi: 10.1038/mt.2011.265. Epub 2011 Dec 6. Mol Ther. 2012. PMID: 22146341 Free PMC article.

3

miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.

Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X. Li J, et al. BMC Cancer. 2010 Jul 6;10:354. doi: 10.1186/1471-2407-10-354. BMC Cancer. 2010. PMID: 20602797 Free PMC article.

4

Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development.

Yip WK, Cheng AS, Zhu R, Lung RW, Tsang DP, Lau SS, Chen Y, Sung JG, Lai PB, Ng EK, Yu J, Wong N, To KF, Wong VW, Sung JJ, Chan HL. Yip WK, et al. PLoS One. 2011;6(8):e22888. doi: 10.1371/journal.pone.0022888. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829663 Free PMC article.

5

Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T. Ishida H, et al. Biochem Biophys Res Commun. 2011 Aug 19;412(1):92-7. doi: 10.1016/j.bbrc.2011.07.049. Epub 2011 Jul 23. Biochem Biophys Res Commun. 2011. PMID: 21802413

6

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Budhu A, et al. Hepatology. 2008 Mar;47(3):897-907. doi: 10.1002/hep.22160. Hepatology. 2008. PMID: 18176954

7

Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells.

Jin H, Lv S, Yang J, Wang X, Hu H, Su C, Zhou C, Li J, Huang Y, Li L, Liu X, Wu M, Qian Q. Jin H, et al. PLoS One. 2011;6(7):e21307. doi: 10.1371/journal.pone.0021307. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21814544 Free PMC article.

8

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M. Gramantieri L, et al. Cancer Res. 2007 Jul 1;67(13):6092-9. doi: 10.1158/0008-5472.CAN-06-4607. Cancer Res. 2007. PMID: 17616664 Free article.

9

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N. Wong QW, et al. Gastroenterology. 2008 Jul;135(1):257-69. doi: 10.1053/j.gastro.2008.04.003. Epub 2008 Apr 11. Gastroenterology. 2008. PMID: 18555017

10

[Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR].

Liu ZR, Chen XW, Qiao XH, Wang R, Xiang Z. Liu ZR, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Apr;29(4):751-3. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19403413 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results